- Home
- EYEN vs KUKE Comparison
EYEN vs KUKE Comparison
Compare EYEN & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- KUKE
- Stock Information
- Founded
- EYEN 2014
- KUKE 2002
- Country
- EYEN United States
- KUKE China
- Employees
- EYEN N/A
- KUKE N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- KUKE Other Consumer Services
- Sector
- EYEN Health Care
- KUKE Real Estate
- Exchange
- EYEN Nasdaq
- KUKE Nasdaq
- Market Cap
- EYEN 38.2M
- KUKE 49.8M
- IPO Year
- EYEN 2018
- KUKE 2021
- Fundamental
- Price
- EYEN $0.55
- KUKE $0.90
- Analyst Decision
- EYEN Strong Buy
- KUKE
- Analyst Count
- EYEN 2
- KUKE 0
- Target Price
- EYEN $12.00
- KUKE N/A
- AVG Volume (30 Days)
- EYEN 879.0K
- KUKE 834.1K
- Earning Date
- EYEN 11-11-2024
- KUKE 11-05-2024
- Dividend Yield
- EYEN N/A
- KUKE N/A
- EPS Growth
- EYEN N/A
- KUKE N/A
- EPS
- EYEN N/A
- KUKE N/A
- Revenue
- EYEN $31,405.00
- KUKE $14,784,158.00
- Revenue This Year
- EYEN $50,309.30
- KUKE N/A
- Revenue Next Year
- EYEN $421.63
- KUKE N/A
- P/E Ratio
- EYEN N/A
- KUKE N/A
- Revenue Growth
- EYEN N/A
- KUKE N/A
- 52 Week Low
- EYEN $0.37
- KUKE $0.47
- 52 Week High
- EYEN $2.57
- KUKE $4.07
- Technical
- Relative Strength Index (RSI)
- EYEN 52.60
- KUKE 56.06
- Support Level
- EYEN $0.52
- KUKE $0.47
- Resistance Level
- EYEN $0.59
- KUKE $1.00
- Average True Range (ATR)
- EYEN 0.05
- KUKE 0.16
- MACD
- EYEN 0.01
- KUKE 0.03
- Stochastic Oscillator
- EYEN 66.45
- KUKE 84.92
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
About KUKE Kuke Music Holding Limited
Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.